Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008
NCT01333462
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
199
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult Volunteers
Interventions
BIOLOGICAL:
NB-1008
OTHER:
Control
Sponsor
NanoBio Corporation